Senseonics Holdings, Inc. a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that three more Blue Cross Blue Shield plans are now providing coverage for the Eversense® CGM System, effective immediately. These recent coverage decisions add to the growing number of payers who are writing Eversense into their CGM coverage policies, as well as

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the advancement of its medical-grade biosensor product portfolio and Data-as-a-Service (DaaS) platform with the introduction of the BioButton™ device.  The BioButton is a coin-sized, disposable medical device that measures continuous temperature and other vital signs for a remarkable 90-days.  BioIntelliSense offers medical-grade data services that allow for early detection

As part of its continued efforts to further transform patient care, DaVita today unveiled DaVita Venture Group (DVG). This group plans to accelerate DaVita's efforts to develop and deploy solutions that are designed to improve the health care and quality of life for people with kidney disease and related chronic conditions. "Innovation should never stop when there is an opportunity to improve patient care," said Javier Rodriguez, CEO of DaVita. "We want to transfo

Fiagon, a technology leader who develops and manufactures innovative surgical image guidance technologies, announced today a partnership with Smith+Nephew (NYSE: SNN, LSE: SN), a global medical technology business, to distribute its ENT surgical navigation portfolio in the Asia Pacific Asean region. This agreement covers China, the India subcontinent, Australia, New Zealand, and other ASEAN markets. "We are excited to partner with a well-established and reputable company such a

SARASOTA, Fla., March 6, 2020 /PRNewswire/ -- New data from a clinical trial of Alzheimer's Disease using a drug called Nilvadipine identified by researchers at the Roskamp Institute show that patients with very mild (very early stage) Alzheimer's disease show less cognitive decline over an 18-month period than placebo-treated patients. On the key clinical meas

WASHINGTON, March 6, 2020 /PRNewswire/ -- On March 5, U.S. House and Senate lawmakers introduced the VALID Act, which would give the Food and Drug Administration (FDA) new, expansive powers to regulate laboratory developed tests—tests that are already regulated by the Centers for Medicare and Medicaid Services (CMS) and are subjec

CHICAGO, March 6, 2020 /PRNewswire/ -- MedVet is providing complimentary eye exams in the month of May to service and working animals as part of the annual ACVO/Epicur National Service Animal Eye Exam Event.

WASHINGTON, March 6, 2020 /PRNewswire/ -- The American Pharmacists Association (APhA) recommends that patients and/or caregivers ensure that they have adequate supplies of necessary medications to address their needs if not able to get to the pharmacy because of coronavirus. If their medication supplies are low, patients should check their prescription benefit cover

COSHOCTON, Ohio, March 6, 2020 /PRNewswire/ -- Even as Natural Products Expo West, the world's largest natural, organic and healthy lifestyle buyer tradeshow postponed its event schedule this week, Wiley's Finest® decided 'the show must go on' (virtually), and is proceeding with their planned launch of 3 new product formulas that will serve the needs of the plan

PITTSBURGH, March 6, 2020 /PRNewswire/ -- "I thought that a truss could be designed differently so that it offered better support and management for treating an inguinal hernia," said an inventor from New Orleans, La.